T lymphocytes export proteasomes by way of microparticles: a possible mechanism for generation of extracellular proteasomes
Open Access
- 31 October 2013
- journal article
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 18 (1) , 59-68
Abstract
The 20S proteasome is almost exclusively localized within cells. High levels of extracellular proteasomes are also found circulating in the blood plasma of patients suffering from a variety of inflammatory, autoimmune and neoplastic diseases. However, the origin of these proteasomes remained enigmatic. Since the proteome of microparticles, small membrane enclosed vesicles released from cells, was shown to contain proteasomal subunits, we studied whether intact proteasomes are actively released into the extracellular space. Using human primary T lymphocytes stimulated with CaCl 2 and the calcium ionophore A23187 to induce membrane blebbing we demonstrate that microparticles contain proteolytically active 20S proteasomes as well as the proteasome activator PA28 and subunits of the 19S proteasome regulator. Furthermore, our experiments reveal that incubation of in vitro generated T lymphocyte‐microparticles with sphingomyelinase results in the hydrolysis of the microparticle membranes and subsequent release of proteasomes from the vesicles. Thus, we here show for the first time that functional proteasomes can be exported from activated immune cells by way of microparticles, the dissolution of which may finally lead to the generation of extracellular proteasomes.Keywords
This publication has 46 references indexed in Scilit:
- Emerging roles of immunoproteasomes beyond MHC class I antigen processingCellular and Molecular Life Sciences, 2012
- Immunoproteasomes at the interface of innate and adaptive immune responses: two faces of one enzymeCurrent Opinion in Immunology, 2012
- The prognostic impact of circulating proteasome concentrations in patients with epithelial ovarian cancerGynecologic Oncology, 2011
- Diagnostic value and prognostic significance of plasmatic proteasome level in patients with melanomaExperimental Dermatology, 2010
- Plasma proteasome level is a reliable early marker of malignant transformation of liver cirrhosisGut, 2009
- Circulating 20S Proteasome Levels in Patients with Mixed Connective Tissue Disease and Systemic Lupus ErythematosusClinical and Vaccine Immunology, 2008
- Circulating proteasome levels are an independent prognostic factor for survival in multiple myelomaBlood, 2006
- Circulating Proteasomes Are Functional and Have a Subtype Pattern Distinct from 20S Proteasomes in Major Blood CellsClinical Chemistry, 2006
- STRUCTURE AND FUNCTIONS OF THE 20S AND 26S PROTEASOMESAnnual Review of Biochemistry, 1996
- Serum concentration and localization in tumor cells of proteasomes in patients with hematologic malignancy and their pathophysiologic significance.1993